A new study has found that when it comes to the neuroprotective abilities of diabetes medications, people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users
Cozma-Petru A, Loghin F, Miere D, Dumitracu DL
Its time for a new conversation
Researchers sourcing GLP-3 RT for preclinical studies, referred to in the Midwest Peptide catalog as GLP-3 RT, need a supplier that understands the analytical demands of a triple incretin receptor agonist
Most providers avoid this concentration for higher doses because of the large injection volumes involved
The FDA raided the Amino Asylum warehouse, and within hours, the entire operation ceased to exist in any functional capacity